LifeMD (LFMDP) Competitors $23.94 -0.24 (-0.97%) Closing price 07/23/2025 02:51 PM EasternExtended Trading$23.82 -0.12 (-0.52%) As of 04:05 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsDividendHeadlinesInsider TradesSEC FilingsShort InterestTrendsBuy This Stock LFMDP vs. ACONW, AONC, DHACW, FMS, OTRKP, PIIIW, TALKW, TOIIW, NTRA, and HIMSShould you be buying LifeMD stock or one of its competitors? The main competitors of LifeMD include Aclarion (ACONW), American Oncology Network (AONC), Digital Health Acquisition (DHACW), Fresenius Medical Care AG & Co. KGaA (FMS), Ontrak (OTRKP), P3 Health Partners (PIIIW), Talkspace (TALKW), Oncology Institute (TOIIW), Natera (NTRA), and Hims & Hers Health (HIMS). These companies are all part of the "healthcare" industry. LifeMD vs. Its Competitors Aclarion American Oncology Network Digital Health Acquisition Fresenius Medical Care AG & Co. KGaA Ontrak P3 Health Partners Talkspace Oncology Institute Natera Hims & Hers Health Aclarion (NASDAQ:ACONW) and LifeMD (NASDAQ:LFMDP) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, profitability, institutional ownership, valuation, earnings, dividends and media sentiment. Does the media favor ACONW or LFMDP? In the previous week, Aclarion had 1 more articles in the media than LifeMD. MarketBeat recorded 1 mentions for Aclarion and 0 mentions for LifeMD. Aclarion's average media sentiment score of 0.00 equaled LifeMD'saverage media sentiment score. Company Overall Sentiment Aclarion Neutral LifeMD Neutral Which has preferable earnings & valuation, ACONW or LFMDP? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAclarion$54.60KN/AN/AN/AN/ALifeMD$234.01MN/AN/AN/AN/A Is ACONW or LFMDP more profitable? Company Net Margins Return on Equity Return on Assets AclarionN/A N/A N/A LifeMD N/A N/A N/A SummaryAclarion and LifeMD tied by winning 1 of the 2 factors compared between the two stocks. Get LifeMD News Delivered to You Automatically Sign up to receive the latest news and ratings for LFMDP and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding LFMDP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LFMDP vs. The Competition Export to ExcelMetricLifeMDHealth Information Services IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$222.48M$5.57B$9.42BDividend Yield11.99%5.90%4.05%3.99%P/E RatioN/A382.1828.1520.08Price / SalesN/A230.74401.6884.07Price / CashN/A47.1436.1958.45Price / BookN/A5.238.625.83Net IncomeN/A-$15.55M$3.24B$258.27M7 Day Performance5.41%0.68%3.55%2.69%1 Month Performance-0.87%0.22%11.01%12.91%1 Year Performance8.82%7.78%35.56%21.81% LifeMD Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LFMDPLifeMDN/A$23.95-1.0%N/A+6.6%$0.00$234.01M0.00230High Trading VolumeACONWAclarionN/A$0.02+4.1%N/A-16.7%$0.00$54.60K0.007Gap UpAONCAmerican Oncology NetworkN/A$10.00+1.0%N/A+363.9%$0.00$1.34B0.001,520DHACWDigital Health AcquisitionN/A$0.04flatN/A-71.2%$0.00N/A0.00N/AFMSFresenius Medical Care AG & Co. KGaA3.6174 of 5 stars$26.88-1.0%$27.80+3.4%+36.9%$0.00$20.63B24.001,384Upcoming EarningsOTRKPOntrakN/A$0.26+13.3%N/A+21.1%$0.00$10.84M0.00250PIIIWP3 Health PartnersN/A$0.01+20.5%N/AN/A$0.00$1.49B0.00500Gap UpTALKWTalkspaceN/A$0.08+15.1%N/A-15.1%$0.00$194.36M0.00500Positive NewsGap UpTOIIWOncology InstituteN/A$0.09-1.0%N/A+342.4%$0.00$403.15M0.00660Positive NewsNTRANatera2.8347 of 5 stars$149.85-5.3%$184.63+23.2%+29.4%$20.46B$1.83B-101.944,434Trending NewsInsider TradeAnalyst RevisionHIMSHims & Hers Health2.5431 of 5 stars$50.44-3.1%$39.58-21.5%+154.7%$11.29B$1.48B73.111,637Trending NewsInsider Trade Related Companies and Tools Related Companies ACONW Alternatives AONC Alternatives DHACW Alternatives FMS Alternatives OTRKP Alternatives PIIIW Alternatives TALKW Alternatives TOIIW Alternatives NTRA Alternatives HIMS Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:LFMDP) was last updated on 7/24/2025 by MarketBeat.com Staff From Our PartnersBuffett to put 90% of his money in this one stock?CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accoun...Altimetry | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredI was wrong about TrumpAddiction. Crime. Corruption. One devastating lie may be fueling it all. A new exposé reveals the hidden ca...Porter & Company | SponsoredFREE GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...GoldCo Precious Metals | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LifeMD, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share LifeMD With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
